Literature DB >> 1969336

Natural killer cell-mediated lysis of T cell lines chronically infected with HIV-1.

S Bandyopadhyay1, U Ziegner, D E Campbell, D S Miller, J A Hoxie, S E Starr.   

Abstract

The susceptibility of HIV-1-infected CD4+ T cell lines to natural killer (NK) cell-mediated lysis was examined. Non-adherent peripheral blood mononuclear cells (PBMC) of healthy adults lysed HUT cells chronically infected with the IIIB or WMJ1 strains of HIV-1 to a significantly greater extent than uninfected HUT cells. In contrast, Sup-T1 cells chronically infected with these two strains of HIV-1 were not lysed to a greater extent than uninfected Sup-T1 cells. Clone A1.25-infected Sup-T1 (A1.25/Sup-T1), derived from IIIB-infected Sup-T1 cells (IIIB/Sup-T1), were susceptible to non-adherent PBMC-mediated lysis, as were A1.25-infected HUT cells (A1.25/HUT). When non-adherent PBMC were depleted of CD16 (Leu-11b)+ NK cells by treatment with anti-Leu-11b plus C, lysis of HIV-1-infected HUT or Sup-T1 cells was reduced to low levels, indicating that the lysis was mediated by NK cells. Expression of HIV antigens on these target cells did not correlate with their susceptibility to NK cell-mediated lysis. Depletion of interferon-alpha (IFN-alpha) producing HLA-DR+ cells from non-adherent PBMC had no effect on the magnitude of NK cell-mediated lysis of IIIB or WMJ1-infected HUT cells. In contrast, lysis of A1.25/Sup-T1 or A1.25/HUT cells required the presence of HLA-DR+ cells. IFN-alpha production appeared to be required for NK cell-mediated lysis of A1.25/Sup-T1 or A1.25/HUT cells, while lysis of HUT cells infected with the WMJ1 or IIIB strains of HIV-1 was IFN-alpha independent. These results indicate considerable variability in the susceptibility of different HIV-1 infected T cell lines to NK cell-mediated lysis and suggest the existence of alternative mechanisms of activation of NK cells for lysis of HIV-1-infected T cell lines.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1969336      PMCID: PMC1534966          DOI: 10.1111/j.1365-2249.1990.tb08107.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  25 in total

1.  Alterations in T4 (CD4) protein and mRNA synthesis in cells infected with HIV.

Authors:  J A Hoxie; J D Alpers; J L Rackowski; K Huebner; B S Haggarty; A J Cedarbaum; J C Reed
Journal:  Science       Date:  1986-11-28       Impact factor: 47.728

Review 2.  Regulation of virus infections by natural killer cells. A review.

Authors:  R M Welsh
Journal:  Nat Immun Cell Growth Regul       Date:  1986

3.  Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, the retrovirus of AIDS.

Authors:  B R Starcich; B H Hahn; G M Shaw; P D McNeely; S Modrow; H Wolf; E S Parks; W P Parks; S F Josephs; R C Gallo
Journal:  Cell       Date:  1986-06-06       Impact factor: 41.582

4.  Persistent noncytopathic infection of normal human T lymphocytes with AIDS-associated retrovirus.

Authors:  J A Hoxie; B S Haggarty; J L Rackowski; N Pillsbury; J A Levy
Journal:  Science       Date:  1985-09-27       Impact factor: 47.728

5.  Continuous production of a cytopathic human T-lymphotropic virus in a permissive neoplastic T-cell line.

Authors:  J P Getchell; J L Heath; D R Hicks; C Sporborg; C R McGrath; V S Kalyanaraman
Journal:  J Clin Microbiol       Date:  1986-04       Impact factor: 5.948

6.  Analysis of effector mechanisms against HTLV-I- and HTLV-III/LAV-infected lymphoid cells.

Authors:  F W Ruscetti; J A Mikovits; V S Kalyanaraman; R Overton; H Stevenson; K Stromberg; R B Herberman; W L Farrar; J R Ortaldo
Journal:  J Immunol       Date:  1986-05-15       Impact factor: 5.422

7.  Pronounced antiviral activity of human interferon on bovine and porcine cells.

Authors:  I Gresser; M T Bandu; D Brouty-boye; M Tovey
Journal:  Nature       Date:  1974-10-11       Impact factor: 49.962

8.  The Fc receptor for IgG on human natural killer cells: phenotypic, functional, and comparative studies with monoclonal antibodies.

Authors:  B Perussia; G Trinchieri; A Jackson; N L Warner; J Faust; H Rumpold; D Kraft; L L Lanier
Journal:  J Immunol       Date:  1984-07       Impact factor: 5.422

9.  CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication.

Authors:  C M Walker; D J Moody; D P Stites; J A Levy
Journal:  Science       Date:  1986-12-19       Impact factor: 47.728

10.  Requirement for HLA-DR+ accessory cells in natural killing of cytomegalovirus-infected fibroblasts.

Authors:  S Bandyopadhyay; B Perussia; G Trinchieri; D S Miller; S E Starr
Journal:  J Exp Med       Date:  1986-07-01       Impact factor: 14.307

View more
  15 in total

1.  In vitro infection of natural killer cells with different human immunodeficiency virus type 1 isolates.

Authors:  J Chehimi; S Bandyopadhyay; K Prakash; B Perussia; N F Hassan; H Kawashima; D Campbell; J Kornbluth; S E Starr
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

2.  Human immunodeficiency virus type 1 infection is associated with increased NK cell polyfunctionality and higher levels of KIR3DL1+ NK cells in ugandans carrying the HLA-B Bw4 motif.

Authors:  Michael A Eller; Rebecca N Koehler; Gustavo H Kijak; Leigh Anne Eller; David Guwatudde; Mary A Marovich; Nelson L Michael; Mark S de Souza; Fred Wabwire-Mangen; Merlin L Robb; Jeffrey R Currier; Johan K Sandberg
Journal:  J Virol       Date:  2011-03-16       Impact factor: 5.103

3.  Deficient antibody-dependent cellular cytotoxicity against human immunodeficiency virus (HIV)-expressing target cells in perinatal HIV infection.

Authors:  U Ziegner; D Campbell; K Weinhold; I Frank; R Rutstein; S E Starr
Journal:  Clin Diagn Lab Immunol       Date:  1999-09

4.  Selective serotonin reuptake inhibitor suppression of HIV infectivity and replication.

Authors:  Tami Benton; Kevin Lynch; Benoit Dubé; David R Gettes; Nancy B Tustin; Jian Ping Lai; David S Metzger; Joshua Blume; Steven D Douglas; Dwight L Evans
Journal:  Psychosom Med       Date:  2010-10-14       Impact factor: 4.312

5.  Changes in natural immunity during the course of HIV-1 infection.

Authors:  B G Brenner; C Gryllis; M Gornitsky; M A Wainberg
Journal:  Clin Exp Immunol       Date:  1993-08       Impact factor: 4.330

6.  Increased LAK activity against HIV-infected cell lines in HIV-1+ individuals.

Authors:  C Gryllis; M A Wainberg; Z Bentwich; M Gornitsky; B G Brenner
Journal:  Clin Exp Immunol       Date:  1992-09       Impact factor: 4.330

7.  Human uterine natural killer cells but not blood natural killer cells inhibit human immunodeficiency virus type 1 infection by secretion of CXCL12.

Authors:  Teddy F Mselle; Alexandra L Howell; Mimi Ghosh; Charles R Wira; Charles L Sentman
Journal:  J Virol       Date:  2009-08-19       Impact factor: 5.103

8.  Selective serotonin reuptake inhibitor and substance P antagonist enhancement of natural killer cell innate immunity in human immunodeficiency virus/acquired immunodeficiency syndrome.

Authors:  Dwight L Evans; Kevin G Lynch; Tami Benton; Benoit Dubé; David R Gettes; Nancy B Tustin; Jian Ping Lai; David Metzger; Steven D Douglas
Journal:  Biol Psychiatry       Date:  2007-10-22       Impact factor: 13.382

Review 9.  HIV-1 Vpu interference with innate cell-mediated immune mechanisms.

Authors:  Johan K Sandberg; Sofia K Andersson; Susanna M Bächle; Douglas F Nixon; Markus Moll
Journal:  Curr HIV Res       Date:  2012-06       Impact factor: 1.581

Review 10.  A dendrite in every pie: myeloid dendritic cells in HIV and SIV infection.

Authors:  Elizabeth R Wonderlich; Simon M Barratt-Boyes
Journal:  Virulence       Date:  2012-11-15       Impact factor: 5.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.